Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

Sarclisa SC approved in EU: first anticancer via on-body injector CirCLIQ®. Flexible home/clinic administration for multiple myeloma patients.
June 08, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : Sarclisa en formulation sous-cutanée de Sanofi approuvé dans l’UE comme premier traitement anticancéreux administré via un injecteur portable

Sarclisa SC approuvé en UE : 1er anticancéreux via injecteur corporel CirCLIQ®. Administration flexible domicile/clinique pour myélome multiple.